No Record Found
CALLS | PUTS | |||||||||
Total OI | Chg in Ol | Chg % Ol | LTP | Chg % | Strike Price | Chg % | LTP | Chg % OI | Chg in Ol | Total OI |
No Record Found
sector: Pharmaceuticals
as on 5/7/2024 10:34:59 AM
₹ 1114.25 -16.30 -1.44No Record Found
No Record Found
Resolution Type | Desc. of Resolution | Lias Recommendation |
---|
Invest wise with Expert advice
Get better recommendations Make better investments.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
Demat Account
Trading Account
PROMOTER - TOTAL62.13%
Indian: 62.13%
Foreign: 0%
NON-PROMOTER - TOTAL 37.87%
Institutions: 2.65%
Non-Institutions: 35.22%
CUSTODIES - 0.00%
Custodies: 0.00%
Y/e 31 Mar ( In .Cr) | -- | -- | -- | -- |
---|---|---|---|---|
Revenue | -- | -- | -- | -- |
yoy growth (%) | -- | -- | -- | -- |
Raw materials | -- | -- | -- | -- |
As % of sales | -- | -- | -- | -- |
Employee costs | -- | -- | -- | -- |
As % of sales | -- | -- | -- | -- |
Other costs | -- | -- | -- | -- |
As % of sales | -- | -- | -- | -- |
Operating profit | -- | -- | -- | -- |
OPM | -- | -- | -- | -- |
Depreciation | -- | -- | -- | -- |
Interest expense | -- | -- | -- | -- |
Other income | -- | -- | -- | -- |
Profit before tax | -- | -- | -- | -- |
Taxes | -- | -- | -- | -- |
Tax rate | -- | -- | -- | -- |
Minorities and other | -- | -- | -- | -- |
Adj. profit | -- | -- | -- | -- |
Exceptional items | -- | -- | -- | -- |
Net profit | -- | -- | -- | -- |
yoy growth (%) | -- | -- | -- | -- |
NPM | -- | -- | -- | -- |
Y/e 31 Mar ( In .Cr) | -- | -- | -- | -- |
---|---|---|---|---|
Equity capital | -- | -- | -- | -- |
Preference capital | -- | -- | -- | -- |
Reserves | -- | -- | -- | -- |
Net worth | -- | -- | -- | -- |
Minority interest | -- | -- | -- | -- |
Debt | -- | -- | -- | -- |
Deferred tax liabilities (net) | -- | -- | -- | -- |
Total liabilities | -- | -- | -- | -- |
Fixed assets | -- | -- | -- | -- |
Intangible assets | -- | -- | -- | -- |
Investments | -- | -- | -- | -- |
Deferred tax asset (net) | -- | -- | -- | -- |
Net working capital | -- | -- | -- | -- |
Inventories | -- | -- | -- | -- |
Inventory Days | -- | -- | -- | -- |
Sundry debtors | -- | -- | -- | -- |
Debtor days | -- | -- | -- | -- |
Other current assets | -- | -- | -- | -- |
Sundry creditors | -- | -- | -- | -- |
Creditor days | -- | -- | -- | -- |
Other current liabilities | -- | -- | -- | -- |
Cash | -- | -- | -- | -- |
Total assets | -- | -- | -- | -- |
Y/e 31 Mar ( In .Cr) | -- | -- | -- | -- |
---|---|---|---|---|
Profit before tax | -- | -- | -- | -- |
Depreciation | -- | -- | -- | -- |
Tax paid | -- | -- | -- | -- |
Working capital | -- | -- | -- | -- |
Other operating items | -- | -- | -- | -- |
Operating cashflow | -- | -- | -- | -- |
Capital expenditure | -- | -- | -- | -- |
Free cash flow | -- | -- | -- | -- |
Equity raised | -- | -- | -- | -- |
Investments | -- | -- | -- | -- |
Debt financing/disposal | -- | -- | -- | -- |
Dividends paid | -- | -- | -- | -- |
Other items | -- | -- | -- | -- |
Net in cash | -- | -- | -- | -- |
Y/e 31 Mar ( In .Cr) | -- | -- | -- | -- |
---|---|---|---|---|
Growth matrix (%) | -- | -- | -- | -- |
Revenue growth | -- | -- | -- | -- |
Op profit growth | -- | -- | -- | -- |
EBIT growth | -- | -- | -- | -- |
Net profit growth | -- | -- | -- | -- |
Profitability ratios (%) | -- | -- | -- | -- |
OPM | -- | -- | -- | -- |
EBIT margin | -- | -- | -- | -- |
Net profit margin | -- | -- | -- | -- |
RoCE | -- | -- | -- | -- |
RoNW | -- | -- | -- | -- |
RoA | -- | -- | -- | -- |
Per share ratios (₹) | -- | -- | -- | -- |
EPS | -- | -- | -- | -- |
Dividend per share | -- | -- | -- | -- |
Cash EPS | -- | -- | -- | -- |
Book value per share | -- | -- | -- | -- |
Valuation ratios | -- | -- | -- | -- |
P/E | -- | -- | -- | -- |
P/CEPS | -- | -- | -- | -- |
P/B | -- | -- | -- | -- |
EV/EBIDTA | -- | -- | -- | -- |
Payout (%) | -- | -- | -- | -- |
Dividend payout | -- | -- | -- | -- |
Tax payout | -- | -- | -- | -- |
Liquidity ratios | -- | -- | -- | -- |
Debtor days | -- | -- | -- | -- |
Inventory days | -- | -- | -- | -- |
Creditor days | -- | -- | -- | -- |
Leverage ratios | -- | -- | -- | -- |
Interest coverage | -- | -- | -- | -- |
Net debt / equity | -- | -- | -- | -- |
Net debt / op. profit | -- | -- | -- | -- |
Cost breakup (₹) | -- | -- | -- | -- |
Material costs | -- | -- | -- | -- |
Employee costs | -- | -- | -- | -- |
Other costs | -- | -- | -- | -- |
Particulars ( Rupees In Crores.) | -- | -- | -- | -- | -- |
---|---|---|---|---|---|
Gross Sales | -- | -- | -- | -- | |
Excise Duty | -- | -- | -- | -- | |
Net Sales | -- | -- | -- | -- | |
Other Operating Income | -- | -- | -- | -- | |
Other Income | -- | -- | -- | -- | |
Total Income | -- | -- | -- | -- | |
Total Expenditure ** | -- | -- | -- | -- | |
PBIDT | -- | -- | -- | -- | |
Interest | -- | -- | -- | -- | |
PBDT | -- | -- | -- | -- | |
Depreciation | -- | -- | -- | -- | |
Minority Interest Before NP | -- | -- | -- | -- | |
Tax | -- | -- | -- | -- | |
Deferred Tax | -- | -- | -- | -- | |
Reported Profit After Tax | -- | -- | -- | -- | |
Minority Interest After NP | -- | -- | -- | -- | |
Net Profit after Minority Interest | -- | -- | -- | -- | |
Extra-ordinary Items | -- | -- | -- | -- | |
Adjusted Profit After Extra-ordinary item | -- | -- | -- | -- | |
EPS (Unit Curr.) | -- | -- | -- | -- | |
Book Value (Unit Curr.) | -- | -- | -- | -- | |
Dividend (%) | -- | -- | -- | -- | |
Equity | -- | -- | -- | -- | |
Public Shareholding (Number) | -- | -- | -- | -- | |
Public Shareholding (%) | -- | -- | -- | -- | |
Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | |
Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | |
Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | |
Non Encumbered - No. of Shares | -- | -- | -- | -- | |
Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | |
Non Encumbered - % in Total Equity | -- | -- | -- | -- | |
PBIDTM(%) | -- | -- | -- | -- | |
PBDTM(%) | -- | -- | -- | -- | |
PATM(%) | -- | -- | -- | -- |
No Record Found
Particulars ( Rupees In Crores.) | -- | -- | -- | -- | -- |
---|---|---|---|---|---|
Gross Sales | -- | -- | -- | -- | |
Excise Duty | -- | -- | -- | -- | |
Net Sales | -- | -- | -- | -- | |
Other Operating Income | -- | -- | -- | -- | |
Other Income | -- | -- | -- | -- | |
Total Income | -- | -- | -- | -- | |
Total Expenditure ** | -- | -- | -- | -- | |
PBIDT | -- | -- | -- | -- | |
Interest | -- | -- | -- | -- | |
PBDT | -- | -- | -- | -- | |
Depreciation | -- | -- | -- | -- | |
Minority Interest Before NP | -- | -- | -- | -- | |
Tax | -- | -- | -- | -- | |
Deferred Tax | -- | -- | -- | -- | |
Reported Profit After Tax | -- | -- | -- | -- | |
Minority Interest After NP | -- | -- | -- | -- | |
Net Profit after Minority Interest | -- | -- | -- | -- | |
Extra-ordinary Items | -- | -- | -- | -- | |
Adjusted Profit After Extra-ordinary item | -- | -- | -- | -- | |
EPS (Unit Curr.) | -- | -- | -- | -- | |
Book Value (Unit Curr.) | -- | -- | -- | -- | |
Dividend (%) | -- | -- | -- | -- | |
Equity | -- | -- | -- | -- | |
Public Shareholding (Number) | -- | -- | -- | -- | |
Public Shareholding (%) | -- | -- | -- | -- | |
Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | |
Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | |
Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | |
Non Encumbered - No. of Shares | -- | -- | -- | -- | |
Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | |
Non Encumbered - % in Total Equity | -- | -- | -- | -- | |
PBIDTM(%) | -- | -- | -- | -- | |
PBDTM(%) | -- | -- | -- | -- | |
PATM(%) | -- | -- | -- | -- |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd | 1,530.00 | 89.09 | 3,67,026.27 | 721.31 | 0.75 | 4,903.66 | 100.23 |
Cipla Ltd | 1,404.10 | 34.95 | 1,14,924.60 | 1,114.14 | 0.60 | 3,798.31 | 320.56 |
Divis Laboratories Ltd | 3,911.25 | 77.07 | 1,05,128.21 | 358.00 | 0.76 | 1,808.00 | 474.52 |
Dr Reddys Laboratories Ltd | 6,290.00 | 26.41 | 1,05,108.85 | 475.20 | 0.63 | 4,083.10 | 1,361.85 |
Zydus Lifesciences Ltd | 1,007.40 | 38.23 | 1,02,736.49 | 450.40 | 0.59 | 2,225.10 | 145.11 |
Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta. The Company belongs to a renowned industrial house of Kolkata, the Kothari Group. The Companys principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export. Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers.ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.87. It has also set up a new unit in Kalyani, West Bengal, to manufacture bulk drugs, which went on stream in 1990. Another rights issue in Mar.90 augmented the long-term working capital. ADL has entered into technical collaboration with Pharma Plan, Germany, to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68-cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad.During 1998-99, the company has developed some new products viz. Siozole Capsules and Ferrochelate-Z-Capsules with Iron & Zinc and folic acid in sustained released formulation. In 2002-03 the company... Read More
Reports by Albert David Ltd
Reports by Albert David Ltd
No Record Found
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.